News | April 09, 2009

CCTA Dose Lowered in Triple Rule-Out


April 9, 2009 -Physicians can dramatically reduce the radiation dose delivered to patients undergoing coronary CT angiography in a "triple rule-out" protocol by simply using tube current modulation, according to a study performed at Thomas Jefferson University Hospital in Philadelphia, PA.

The study included 172 patients who were evaluated using coronary CT angiography without tube current modulation and 95 patients who were evaluated with tube current modulation. The effective radiation dose ranged between 9.9 and 31.3 mSv in patients without modulation; the dose ranged between 5.4 and 16.6 mSv in patients with modulation. "Image quality was comparable to when we didn't use tube current modulation," said Kevin M. Takakuwa, M.D., lead author of the study.

"One of the major criticisms of the triple rule out coronary CT angiography study is the concern about the high amount of radiation given, which has been estimated by some to be as high as 30-40 mSv. Our study demonstrates that the radiation is a lot less, averaging less than 9 mSv when using tube current modulation. In addition, it uses less radiation than a nuclear stress test, a common alternative study to the triple rule-out cardiac CT," he said.

"Cardiac CT in a "triple rule-out" protocol allows us to look for coronary artery disease, aortic dissections and pulmonary emboli. These are three potentially life-threatening causes of chest pain that we cannot afford to miss in the emergency room. When we perform this test on undifferentiated chest pain patients we are able to identify disease entities that cannot be made with nuclear stress testing. For example, we have diagnosed metastatic cancers, pulmonary embolism and pneumonia that would have been missed by stress testing alone. Cardiac CT is also much quicker than a stress test and can save people from getting an invasive cardiac catheterization," said Dr. Takakuwa.

"Our goal is to be able to perform cardiac CT using tube current modulation 24/7 and as a means to be able to admit or discharge patients more rapidly," he said.

Source: This study appears in the April issue of the American Journal of Roentgenology.

For more information: www.ajronline.org


Related Content

News | Computed Tomography (CT)

July 16, 2024 — Arineta, a leader in advancing cardiovascular imaging solutions through cutting-edge technology, proudly ...

Home July 16, 2024
Home
News | Computed Tomography (CT)

May 1, 2024 —In this 3-stage study, 3 cohorts were used for diagnostic performance, and prognostic performance ...

Home May 01, 2024
Home
News | Computed Tomography (CT)

April 22, 2024 — A new study showed that a non-invasive imaging test can help identify patients with coronary artery ...

Home April 22, 2024
Home
Feature | Computed Tomography (CT) | By Alberto Morales, MD

Cardiac CT scans, recommended by the American College of Cardiology (ACC) and the American Heart Association (AHA) as ...

Home March 20, 2024
Home
News | Computed Tomography (CT)

February 20, 2024 — Ultrahigh-spatial-resolution photon-counting detector CT improved assessment of coronary artery ...

Home February 20, 2024
Home
News | Computed Tomography (CT)

HeartFlow is offering a free webinar based on a recent study that measured the ability of the of its roadmap analysis to ...

Home January 15, 2024
Home
News | Computed Tomography (CT)

December 19, 2023 — Siemens Healthineers announced the Food and Drug Administration (FDA) clearance of the Somatom Pro ...

Home December 19, 2023
Home
Feature | Computed Tomography (CT) | By Andrew Michalski, PhD and Rohit Sood MD, PhD

Coronary artery disease (CAD), also known as ischemic heart disease, is the most common heart disease with a prevalence ...

Home December 05, 2023
Home
News | Computed Tomography (CT)

October 26, 2023 — HeartFlow, Inc., a leader in non-invasive integrated artificial intelligence (AI) heart care ...

Home October 26, 2023
Home
News | Computed Tomography (CT)

October 13, 2023 — Arineta Cardiac Imaging is excited to announce the FDA 510(k) clearance of the SpotLight and ...

Home October 13, 2023
Home
Subscribe Now